These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 8829885)

  • 1. Epoprostenol increases plasma level of atrial natriuretic peptide in humans.
    Nielsen CB; Bech JN; Pedersen EB
    Clin Sci (Lond); 1996 Feb; 90(2):87-9. PubMed ID: 8829885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study.
    Nielsen CB; Bech JN; Pedersen EB
    Br J Clin Pharmacol; 1997 Nov; 44(5):471-6. PubMed ID: 9384464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained.
    Kingma K; Wollersheim H; Thien T
    J Cardiovasc Pharmacol; 1995 Sep; 26(3):388-93. PubMed ID: 8583779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial natriuretic peptide inhibits fluid intake in hyperosmolar subjects.
    Burrell LM; Palmer JM; Baylis PH
    Clin Sci (Lond); 1992 Jul; 83(1):35-9. PubMed ID: 1325319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of physiological increments in human alpha-atrial natriuretic peptide and human brain natriuretic peptide in normal male subjects.
    Cheung BM; Dickerson JE; Ashby MJ; Brown MJ; Brown J
    Clin Sci (Lond); 1994 Jun; 86(6):723-30. PubMed ID: 8062508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism and action of urodilatin infusion in healthy volunteers.
    Carstens J; Jensen KT; Pedersen EB
    Clin Pharmacol Ther; 1998 Jul; 64(1):73-86. PubMed ID: 9695722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans.
    Oelkers W; Kleiner S; Bähr V
    Hypertension; 1988 Oct; 12(4):462-7. PubMed ID: 2971619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance and pharmacology of ciprostene, a stable epoprostenol (prostacyclin) analogue in humans.
    Linet OI; Nishizawa EE; Schaub RG; VanderLugt JT; Greenwald CA
    J Clin Pharmacol; 1986 Feb; 26(2):131-40. PubMed ID: 3005377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of dopamine infusion on the release of atrial natriuretic factor].
    Fontana F; Ruffini M; Capelli M; Bernardi P
    G Ital Cardiol; 1990 Mar; 20(3):227-35. PubMed ID: 2140554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of atrial natriuretic peptide and brain natriuretic peptide on the aldosterone and pressor responses to angiotensin II in man.
    Cargill RI; Struthers AD; Lipworth BJ
    Clin Sci (Lond); 1995 Jan; 88(1):81-6. PubMed ID: 7705006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of SCH 34826, an orally active inhibitor of atrial natriuretic peptide degradation, in healthy volunteers.
    Burnier M; Ganslmayer M; Perret F; Porchet M; Kosoglou T; Gould A; Nussberger J; Waeber B; Brunner HR
    Clin Pharmacol Ther; 1991 Aug; 50(2):181-91. PubMed ID: 1831083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of atrial natriuretic factor in young and elderly subjects.
    Jansen TL; Tan AC; Smits P; de Boo T; Benraad TJ; Thien T
    Clin Pharmacol Ther; 1990 Aug; 48(2):179-88. PubMed ID: 2143129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of atrial natriuretic peptide (8-33-Met ANP) in patients with hypertension.
    Franco-Saenz R; Somani P; Mulrow PJ
    Am J Hypertens; 1992 May; 5(5 Pt 1):266-75. PubMed ID: 1533767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of atrial natriuretic peptide on blood pressure, guanosine 3':5'-cyclic monophosphate release and blood volume in uraemic patients.
    Jespersen B; Eiskjaer H; Pedersen EB
    Clin Sci (Lond); 1990 Jan; 78(1):67-73. PubMed ID: 2153498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hypotensive and renal effects of atrial natriuretic peptide.
    Granger JP; Opgenorth TJ; Salazar J; Romero JC; Burnett JC
    Hypertension; 1986 Jun; 8(6 Pt 2):II112-6. PubMed ID: 2941368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma ANP during hypertonic NaCl infusion in man.
    Arjamaa O; Karlqvist K; Kanervo A; Vainionpää V; Vuolteenaho O; Leppäluoto J
    Acta Physiol Scand; 1992 Feb; 144(2):113-9. PubMed ID: 1533483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role of atrial natriuretic peptide in ethanol-induced acute diuresis.
    Colantonio D; Casale R; Desiati P; De Michele G; Mammarella M; Pasqualetti P
    Life Sci; 1991; 48(7):635-42. PubMed ID: 1824957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclic guanosine monophosphate response to infusion of atrial natriuretic peptide in young and elderly subjects.
    Tan AC; Jansen TL; Thien T; Kloppenborg PW; Benraad TJ
    J Am Geriatr Soc; 1993 Nov; 41(11):1241-4. PubMed ID: 8227900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
    Kukkonen P; Vuolteenaho O; Ruskoaho H
    Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.